 <h1>Cefepime Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to cefepime: injection powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, cefepime may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking cefepime:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach cramps</li>
<li>back, leg, or stomach pains</li>
<li>bleeding gums, nosebleeds</li>
<li>confusion</li>
<li>convulsions</li>
<li>dark urine</li>
<li>difficulty with breathing</li>
<li>fever, chills</li>
<li>general body swelling</li>
<li>headache</li>
<li>irregular heartbeats</li>
<li>loss of appetite</li>
<li>mood or mental changes</li>
<li>muscle cramps in the hands, arms, feet, legs, or face</li>
<li>nausea or vomiting</li>
<li>numbness and tingling around the mouth, fingertips, or feet</li>
<li>tremor</li>
<li>yellowing of the eyes or skin</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bluish color</li>
<li>pain, tenderness</li>
<li>swelling of the foot or leg</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Diarrhea</li>
<li>inflammation or swelling</li>
<li>watery or bloody diarrhea</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloody or cloudy urine</li>
<li>bloody, black, or tarry stools</li>
<li>blurred vision</li>
<li>change in consciousness</li>
<li>chest pain</li>
<li>cough or hoarseness</li>
<li>difficult or painful urination</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>general feeling of tiredness or weakness</li>
<li>itching, hives</li>
<li>muscle twitching or jerking</li>
<li>paralysis</li>
<li>pinpoint red spots on the skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red skin lesions, often with a purple center</li>
<li>rhythmic movement of the muscles</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>seizures</li>
<li>severe sleepiness</li>
<li>stiff neck</li>
<li>sudden decrease in the amount of urine</li>
<li>swollen or painful glands</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>vomiting of blood</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of cefepime may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Red streaks on the skin</li>
<li>swelling, tenderness, or pain at the injection site</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Itching of the vagina or genital area</li>
<li>pain during sexual intercourse</li>
<li>redness of the skin</li>
<li>sore mouth or tongue</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>white patches in the mouth, tongue, or throat</li>
</ul><p>
<!-- end injection powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cefepime: injectable powder for injection, intravenous powder for injection, intravenous solution</i></p><h3>General</h3><p>The most commonly reported side effects included positive Coombs' Test (without hemolysis), localized reactions, increased ALT, and diarrhea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Positive Coombs' Test without hemolysis (up to 18.7%)</p>
<p><b>Common</b> (1% to 10%): Abnormal partial thromboplastin time (PTT), abnormal prothrombin time (PT), anemia, eosinophilia, PT prolonged, PTT prolonged</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased hematocrit, decreased neutrophils/neutropenia, decreased platelets/thrombocytopenia/transient thrombocytopenia, decreased white blood cell counts/leukopenia/transient leukopenia</p>
<p><b>Rare</b> (0.01% to 0.1%): Transient neutropenia</p>
<p><b>Frequency not reported</b>: Agranulocytosis, aplastic anemia, hemolytic anemia</p>
<p><b>Postmarketing reports</b>: Pancytopenia<sup>[Ref]</sup></p><p>Agranulocytosis, aplastic anemia, hemolytic anemia, neutropenia, pancytopenia, thrombocytopenia, and transient leukopenia were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Liver dysfunction and cholestasis were reported with cephalosporin use.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Alkaline phosphatase increased, blood bilirubin increased, increased ALT, increased AST, increased total bilirubin</p>
<p><b>Postmarketing reports</b>: Cholestasis, liver dysfunction<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site reactions/local reactions, injection site inflammation, injection site pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Infusion site inflammation<sup>[Ref]</sup></p><p>Local reactions included inflammation, pain, phlebitis, and rash, and occurred irrespective to this drug in patients who received IV infusion.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including diarrhea, nausea, and vomiting.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Diarrhea, nausea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Colitis, oral candidiasis, oral moniliasis, pseudomembranous colitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Abdominal pain, constipation</p>
<p><b>Frequency not reported</b>: Clostridium difficile-associated diarrhea, gastrointestinal disorder<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash/skin rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Erythema, urticaria</p>
<p><b>Frequency not reported</b>: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis<sup>[Ref]</sup></p><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including rash and pruritus.</p>
<p></p>
<p>The most frequently reported side effect in pediatric patient was rash.</p>
<p></p>
<p>Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Other</h3><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including fever.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Fever/pyrexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Inflammation, pain</p>
<p><b>Rare</b> (0.01% to 0.1%): Chills<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Phlebitis/infusion site phlebitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Vasodilation</p>
<p><b>Frequency not reported</b>: Hemorrhage<sup>[Ref]</sup></p><p>Hemorrhage was reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Hypocalcemia occurred more frequently in older patients.</p>
<p></p>
<p>False positive glycosuria was reported with cephalosporin use.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Decreased phosphorus</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased calcium, hypocalcemia, increased calcium, increased phosphorus, increased potassium</p>
<p><b>Frequency not reported</b>: False positive glycosuria<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p>
<p><b>Rare</b> (0.01% to 0.1%): Convulsions, dizziness, dysgeusia, paresthesia, taste perversion</p>
<p><b>Very rare</b> (less than 0.01%): Seizures</p>
<p><b>Frequency not reported</b>: Altered state of consciousness/consciousness disorder, coma, encephalopathy, myoclonus, neurotoxicity, stupor</p>
<p><b>Postmarketing reports</b>: Aphasia, nonconvulsive status epilepticus<sup>[Ref]</sup></p><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including headache.</p>
<p></p>
<p>Encephalopathy included coma, confusion, consciousness disorder, hallucinations, and stupor.</p>
<p></p>
<p>Coma, consciousness disorder, convulsions, encephalopathy, myoclonus, and stupor were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Dyspnea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased/increased creatinine, blood urea increased/increased blood urea nitrogen (BUN), transient increase in serum creatinine, transient increase in serum urea, transient uremia</p>
<p><b>Frequency not reported</b>: Renal dysfunction, renal failure, toxic nephropathy<sup>[Ref]</sup></p><p>Renal failure and toxic nephropathy were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Vaginal infection, vaginitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Genital pruritus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction, angioedema</p>
<p><b>Frequency not reported</b>: Anaphylactic shock, anaphylaxis, hypersensitivity reactions<sup>[Ref]</sup></p><p>Anaphylactic shock and anaphylaxis were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (0.01% to 0.1%): Candidiasis, unspecified moniliasis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Confusion and hallucinations were reported with cephalosporin use.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Confusion/state of confusion, hallucinations<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Maxipime (cefepime)." Bristol-Myers Squibb, Princeton, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about cefepime</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: fourth generation cephalosporins</li>
<li>FDA Alerts (4)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Cefepime Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Maxipime</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Kidney Infections</li>
<li>Bacteremia</li>
<li>Febrile Neutropenia</li>
<li>Intraabdominal Infection</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to cefepime: injectable powder for injection, intravenous powder for injection, intravenous solution</i></p><h3>General</h3><p>The most commonly reported side effects included positive Coombs' Test (without hemolysis), localized reactions, increased ALT, and diarrhea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Positive Coombs' Test without hemolysis (up to 18.7%)</p><p><b>Common</b> (1% to 10%): Abnormal partial thromboplastin time (PTT), abnormal prothrombin time (PT), anemia, eosinophilia, PT prolonged, PTT prolonged</p><p><b>Uncommon</b> (0.1% to 1%): Decreased hematocrit, decreased neutrophils/neutropenia, decreased platelets/thrombocytopenia/transient thrombocytopenia, decreased white blood cell counts/leukopenia/transient leukopenia</p><p><b>Rare</b> (0.01% to 0.1%): Transient neutropenia</p><p><b>Frequency not reported</b>: Agranulocytosis, aplastic anemia, hemolytic anemia</p><p><b>Postmarketing reports</b>: Pancytopenia<sup>[Ref]</sup></p><p>Agranulocytosis, aplastic anemia, hemolytic anemia, neutropenia, pancytopenia, thrombocytopenia, and transient leukopenia were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Liver dysfunction and cholestasis were reported with cephalosporin use.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Alkaline phosphatase increased, blood bilirubin increased, increased ALT, increased AST, increased total bilirubin</p><p><b>Postmarketing reports</b>: Cholestasis, liver dysfunction<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site reactions/local reactions, injection site inflammation, injection site pain</p><p><b>Uncommon</b> (0.1% to 1%): Infusion site inflammation<sup>[Ref]</sup></p><p>Local reactions included inflammation, pain, phlebitis, and rash, and occurred irrespective to this drug in patients who received IV infusion.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including diarrhea, nausea, and vomiting.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Diarrhea, nausea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Colitis, oral candidiasis, oral moniliasis, pseudomembranous colitis</p><p><b>Rare</b> (0.01% to 0.1%): Abdominal pain, constipation</p><p><b>Frequency not reported</b>: Clostridium difficile-associated diarrhea, gastrointestinal disorder<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash/skin rash</p><p><b>Uncommon</b> (0.1% to 1%): Erythema, urticaria</p><p><b>Frequency not reported</b>: Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis<sup>[Ref]</sup></p><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including rash and pruritus.</p><p></p><p>The most frequently reported side effect in pediatric patient was rash.</p><p></p><p>Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Other</h3><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including fever.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Fever/pyrexia</p><p><b>Uncommon</b> (0.1% to 1%): Inflammation, pain</p><p><b>Rare</b> (0.01% to 0.1%): Chills<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Phlebitis/infusion site phlebitis</p><p><b>Rare</b> (0.01% to 0.1%): Vasodilation</p><p><b>Frequency not reported</b>: Hemorrhage<sup>[Ref]</sup></p><p>Hemorrhage was reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Hypocalcemia occurred more frequently in older patients.</p><p></p><p>False positive glycosuria was reported with cephalosporin use.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Decreased phosphorus</p><p><b>Uncommon</b> (0.1% to 1%): Decreased calcium, hypocalcemia, increased calcium, increased phosphorus, increased potassium</p><p><b>Frequency not reported</b>: False positive glycosuria<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Rare</b> (0.01% to 0.1%): Convulsions, dizziness, dysgeusia, paresthesia, taste perversion</p><p><b>Very rare</b> (less than 0.01%): Seizures</p><p><b>Frequency not reported</b>: Altered state of consciousness/consciousness disorder, coma, encephalopathy, myoclonus, neurotoxicity, stupor</p><p><b>Postmarketing reports</b>: Aphasia, nonconvulsive status epilepticus<sup>[Ref]</sup></p><p>Higher doses (2 grams every 8 hours) have been associated with a higher incidence of side effects, including headache.</p><p></p><p>Encephalopathy included coma, confusion, consciousness disorder, hallucinations, and stupor.</p><p></p><p>Coma, consciousness disorder, convulsions, encephalopathy, myoclonus, and stupor were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Dyspnea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased/increased creatinine, blood urea increased/increased blood urea nitrogen (BUN), transient increase in serum creatinine, transient increase in serum urea, transient uremia</p><p><b>Frequency not reported</b>: Renal dysfunction, renal failure, toxic nephropathy<sup>[Ref]</sup></p><p>Renal failure and toxic nephropathy were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Vaginal infection, vaginitis</p><p><b>Rare</b> (0.01% to 0.1%): Genital pruritus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction, angioedema</p><p><b>Frequency not reported</b>: Anaphylactic shock, anaphylaxis, hypersensitivity reactions<sup>[Ref]</sup></p><p>Anaphylactic shock and anaphylaxis were reported with cephalosporin use.<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Rare</b> (0.01% to 0.1%): Candidiasis, unspecified moniliasis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Confusion and hallucinations were reported with cephalosporin use.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Confusion/state of confusion, hallucinations<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Maxipime (cefepime)." Bristol-Myers Squibb, Princeton, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about cefepime</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: fourth generation cephalosporins</li>
<li>FDA Alerts (4)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Cefepime Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Kidney Infections</li>
<li>Bacteremia</li>
<li>Febrile Neutropenia</li>
<li>Intraabdominal Infection</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>